Health
-
Why bother?
What makes someone run 26.2 miles? Boston Marathon’s lead psychologist has heard it all.
-
Stopping the bleeding
Terence Blue has spent his life managing hemophilia. A new gene therapy offers relief from constant worry and daily needles — ‘I am actually healing faster than I ever have.’
-
Immune-system strategy used to treat cancer may help with Alzheimer’s
Turning off checkpoint molecules freed microglia to attack plaques in brain, improved memory in mice
-
Is dining with others a sign of happiness?
Shared meals may be a more reliable indicator of well-being than income, Kennedy School researcher says
-
Researchers ID genetic disorders that can be treated before birth
Timely detection could reduce morbidity, offer opportunities for early intervention
-
How to manage stress during an apocalypse
Psychologist says scrutinizing risk factors, embracing community, adventure are key in age of angst over climate, AI, pandemics
-
Researchers replicate ALS process in lab dish
A Harvard Stem Cell Institute (HSCI) research team has succeeded in deriving spinal motor neurons from human embryonic stem cells, and has then used them to replicate the Amyotrophic Lateral Sclerosis (ALS) disease process in a laboratory dish.
-
Researchers successfully track voyage of single stem cell
The title of the letter in the Dec. 3 edition of the journal Nature — “Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche” — doesn’t begin to describe it, this real-life, real-time view of a single stem cell making its way to its ultimate home inside the bone-marrow cavity of a living mouse.
-
Dybul urges partnering with governments, communities to fight AIDS
In honor of World AIDS Day (Dec. 1), Ambassador Mark Dybul, the U.S. global AIDS coordinator who is leading the implementation of the $48 billion President’s Emergency Plan for AIDS Relief (PEPFAR), spoke Dec. 4 in Sever Hall.
-
Rights, AIDS, past and future
Sixty years after the United Nations declared health care a basic human right, the AIDS epidemic highlights how much work remains to be done as the disease rages on among populations with little access to quality care.
-
Research may lead to treatment for retinitis pigmentosa
Rods and cones coexist peacefully in healthy retinas. Both types of cells occupy the same layer of tissue and send signals when they detect light, which is the first step in vision.
-
Hormone therapy for prostate cancer does not appear to increase cardiac deaths
Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Harvard Medical…
-
Fresh insight into retinitis pigmentosa
Rods and cones coexist peacefully in healthy retinas. Both types of cells occupy the same layer of tissue and send signals when they detect light, which is the first step…
-
Connie Cepko
In some ways, Connie Cepko’s job has gotten easier. The Harvard Medical School genetics professor is working to uncover the mysteries of the eye, to understand how it develops and…
-
Another step forward in ALS and stem cell research
A Harvard Stem Cell Institute research team has succeeded in deriving spinal motor neurons from human embryonic stem cells, and has then used them to replicate the Amyotrophic Lateral Sclerosis (ALS) disease process in a laboratory dish.
-
Some blood-system stem cells reproduce more slowly than expected
A research collaboration lead by Harvard Stem Cell Institute researchers at Massachusetts General Hospital (MGH) has found a subpopulation of hematopoietic stem cells, which generate all blood and immune system…
-
Early success highlights need for more progress
Many of the 500,000 African babies born infected with HIV each year won’t live past age 2, a fact made even more appalling by the fact that doctors know how to halt mother-to-child HIV transmission.
-
Cutler finds decline in cancer deaths
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
-
South African AIDS policy tied to 330,000 lives lost
More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert researchers from…
-
Genetic screening no better than traditional risk factors for predicting type 2 diabetes
Screening for a panel of gene variants associated with the risk for type 2 diabetes can identify adults at risk for the disorder but is not significantly better than assessment based on traditional risk factors such as weight, blood pressure, and blood sugar levels.
-
Anesthetic causes changes in mouse brains
For the first time researchers have shown that a commonly used anesthetic can produce changes associated with Alzheimer’s disease in the brains of living mammals, confirming previous laboratory studies. In their Annals of Neurology report, which has received early online release, a team of Massachusetts General Hospital (MGH) investigators shows how administration of the gas isoflurane can lead to generation of the toxic amyloid-beta (A-beta) protein in the brains of mice.
-
For innovative undergrads, bacteria make some buzz
A team of undergraduates who engineered a bacterial biosensor with electrical output recently made some buzz at the 2008 international Genetically Engineered Machine (iGEM) competition held at the Massachusetts Institute of Technology (MIT).
-
A single gene leads yeast cells to cooperate against threats
An ingenious social behavior that mobilizes yeast cells to cooperate in protecting each other from stress, antibiotics, and other dangers is driven by the activity of a single gene, scientists report this week in the journal Cell. The cooperating cells use the same gene, dubbed FLO1, as a marker for detecting “cheaters,” cells that try to profit from the group’s protection without investing in the group’s welfare.
-
Drug trial shows dramatic reduction in hidden heart disease
A Harvard-led study shows that the risk of heart attack and stroke among subjects with “silent heart disease” — and normal cholesterol levels — can be dramatically reduced by the use of an already widely prescribed class of drugs.
-
Common surgical anesthetic induces Alzheimer’s-associated changes in mouse brains
For the first time researchers have shown that a commonly used anesthetic can produce changes associated with Alzheimer’s disease in the brains of living mammals, confirming previous laboratory studies. In…
-
Drug trial shows dramatic reduction in risks posed by hidden heart disease
A Harvard-led study shows that the risk of heart attack and stroke among subjects with “silent heart disease” — and normal cholesterol levels — can be dramatically reduced by the use of an already widely prescribed class of drugs.
-
C. Ronald Kahn first to win Manpei Suzuki International Prize for Diabetes Research
C. Ronald Kahn, M.D., Mary K. Iacocca Professor of Medicine at Harvard Medical School, and head of the Head Section on Obesity and Hormone Action at the Joslin Diabetes Center,…
-
Microbiologist Gary Ruvkun:
Gary Ruvkun has made a career out of imagining the unimaginable, and of surrounding himself with like-minded thinkers who let the wheels of thought spin until they catch on something…
-
Survey finds disconnect between sexual problems in women and feeling of distress
The largest such study ever published finds that, although about 40 percent of women surveyed report having sexual problems, only 12 percent indicate that those issues are a source of…
-
Gene scan of Alzheimer’s families identifies four new suspect genes
The first family-based genome-wide association study in Alzheimer’s disease has identified the sites of four novel genes that may significantly influence risk for the most common late-onset form of the…
-
Health disparities in Boston focus of talk at HSPH Community Partnership Day
Boston Mayor Thomas M. Menino and the city’s top health official, Barbara Ferrer, speaking at the Harvard School of Public Health’s (HSPH) 18th Annual Community Partnership Day, said efforts to end racial health disparities must go forward in the city even as the nation’s economy falters.
-
In survey, patients give some high, some low marks to hospitals
The quality of hospitals across the United States is inconsistent. To address this issue, the federal government and private organizations have begun to publicly report data, such as how well hospitals treat certain conditions. But until now, there has been no data on how patients themselves feel about the care they received. A new study by Harvard School of Public Health (HSPH) researchers analyzed the first national data on patients’ experiences in hospital settings and found that though patients are generally satisfied with their care, there is substantial room for improvement in a number of key areas, including pain management and discharge instructions.
-
Status of women in academe assessed
More than three decades of championing better opportunities for women has yielded critical changes, but there is still work to be done.
-
Obama voters much more likely to believe outcome will impact health care
As part of the ongoing poll series “Debating Health: Election 2008,” the Harvard Public Opinion Research Program at the Harvard School of Public Health (HSPH) and Harris Interactive conducted a new survey focused on whether voters believe the results of this presidential election will make “a great deal of difference” in the state of the nation’s health care and other key policy areas. Although much has been made of voter cynicism in recent times, a majority of registered voters believe the outcome of this election will make a great deal of difference on key issues including the war in Iraq (63 percent), the economy (52 percent), the war in Afghanistan (50 percent), and national security (50 percent). This survey was conducted Oct. 16-19 by telephone among a national cross section of 957 registered voters in the United States.
-
Researchers gain ground in treatment options for disfiguring tumor
A team of researchers led by Harvard School of Dental Medicine (HSDM) Dean for Research Bjorn Olsen has discovered a mechanism for the rapid growth seen in infantile hemangioma, the most common childhood tumor.
-
New Guinea forest expands ‘observatory’
Just getting there takes hours of hot, sweaty hiking through lowland Papua New Guinea forests: three hours from the road to the base camp, then another seven to the site. That’s when the real work begins: tagging, measuring, and identifying 250,000 trees scattered over 50 hectares.